State-of-the-art in transposable element modulation affected by drugs in malignant prostatic cancer cells.

Autor: Terrazzan A; Department of Translational Medicine, University of Ferrara, Ferrara, Italy.; Laboratory for Advanced Therapy Technologies (LTTA), University of Ferrara, Ferrara, Italy., Vanini R; Department of Translational Medicine, University of Ferrara, Ferrara, Italy., Ancona P; Department of Translational Medicine, University of Ferrara, Ferrara, Italy., Bianchi N; Department of Translational Medicine, University of Ferrara, Ferrara, Italy., Taccioli C; Department of Animal Medicine, Production and Health (MAPS), University of Padua, Padua, Italy., Aguiari G; Department of Neuroscience and Rehabilitation, University of Ferrara, Ferrara, Italy.
Jazyk: angličtina
Zdroj: Journal of cellular biochemistry [J Cell Biochem] 2024 May; Vol. 125 (5), pp. e30557. Date of Electronic Publication: 2024 Mar 19.
DOI: 10.1002/jcb.30557
Abstrakt: Over recent years, the investigation of transposable elements (TEs) has granted researchers a deeper comprehension of their characteristics and functions, particularly regarding their significance in the mechanisms contributing to cancer development. This manuscript focuses on prostate carcinoma cell lines and offers a comprehensive review intended to scrutinize the associations and interactions between TEs and genes, as well as their response to treatment using various chemical drugs, emphasizing their involvement in cancer progression. We assembled a compendium of articles retrieved from the PubMed database to construct networks demonstrating correlations with genes and pharmaceuticals. In doing so, we linked the transposition of certain TE types to the expression of specific transcripts directly implicated in carcinogenesis. Additionally, we underline that treatment employing different drugs revealed unique patterns of TE reactivation. Our hypothesis gathers the current understanding and guides research toward evidence-based investigations, emphasizing the association between antiviral drugs, chemotherapy, and the reduced expression of TEs in patients affected by prostate cancer.
(© 2024 Wiley Periodicals LLC.)
Databáze: MEDLINE
Externí odkaz: